Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

CAMP US Equity

Camp4 Therapeutics CorpHealth Care · Pharmaceutical Preparations · CIK 1736730 · FY ends Dec 31
$4.65
-0.25 (-5.10%)
USD · as of 2026-08-19 · marketstack
3 8-K filings · 2 13D · 2 13G
DateEventWhat happened / filerSource
2026-08-1913D/ASchedule 13D amendment — ≥5% beneficial owner (active intent) · by Polaris Management Co. VII, L.L.C.sec.gov ↗
2026-08-1413G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by BALYASNY ASSET MANAGEMENT L.P.sec.gov ↗
2026-08-138-K 2.02Results of operations and financial condition (earnings)earnings history (EARN) →sec.gov ↗
2026-08-1013GSchedule 13G filed — ≥5% beneficial owner (passive) · by Trails Edge Capital Partners, LPsec.gov ↗
2026-08-0513D/ASchedule 13D amendment — ≥5% beneficial owner (active intent) · by 5AM Ventures VI, L.P.sec.gov ↗
2026-08-048-K 7.01Regulation FD disclosuresec.gov ↗
2026-08-048-K 3.02Unregistered sales of equity securitiessec.gov ↗
2026-08-048-K 1.01Entry into a material definitive agreementsec.gov ↗
2026-07-278-K 8.01Other eventssec.gov ↗
2026-07-278-K 7.01Regulation FD disclosuresec.gov ↗
Source: SEC EDGAR (public domain) · history starts 2026-07-27

Every row is a filed document, checked against its EDGAR index.